Assessment of long term safety of DE-109 in patients with non-infectious uveitis of the posterior segment of the eye
- Conditions
- Health Condition 1: H208- Other iridocyclitisHealth Condition 2: H358- Other specified retinal disorders
- Registration Number
- CTRI/2015/07/006025
- Lead Sponsor
- SANTEN INCORPORATED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 0
1. Participated in the SAKURA study
2. Received clinical benefit from treatment in the SAKURA study
3. Ability to sign informed consent and attend all study visits
1.Uveitis of infectious etiology
2.Implanted device
3. Suspected or confirmed central nervous system or ocular lymphoma
4.Uncontrolled glaucoma
5.Significant ocular disease
6.Intravitreal injections in the past 60 days
7.Intraocular surgery or treatment
8.Ocular or periocular infection
9.History of herpetic infection
10.Toxoplasmosis or toxoplasmosis scar
11.Ocular malignancy
12.Vitrectomy
13.Allergy or hypersensitivity to study drug
14.Participation in other uveitis device clinical trials within 30 days
15.Any recent systemic condition/infection
16.Immunosuppressive therapy or immunocomprimised
17.Cytomegalovirus infection
18.Malignancy in remission
19.Females who are pregnant or lactating and who are not using adequate contraceptive
20.Medical marijuana or illegal drug use
21.Systemic saroidosis
22.Therapeutic radiation to the head or neck
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method